Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Kyto Technology & Life Science, Inc. | kbph_10q.htm |
| EX-31.1 - CERTIFICATION - Kyto Technology & Life Science, Inc. | kbph_ex311.htm |
CERTIFICATION
PURSUANT
TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Kyto Biopharma, Inc. and Subsidiary (the
“Company”) on Form 10-Q for the three months ended December 31, 2009, as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Georges Benarroch, President and Chief Executive Officer, certify to my
knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
|
1.
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended;
and,
|
|
2.
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company
as of the dates and for the periods expressed in the
Report.
|
|
Date:
February 12, 2010
|
By:
|
/s/
Georges Benarroch
|
|
Georges
Benarroch
Acting
President & Chief Executive Officer
and
Acting Chief Financial Officer
|